XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.2
BORROWING ACTIVITIES AND ARRANGEMENTS
6 Months Ended
Jun. 30, 2025
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]  
BORROWING ACTIVITIES AND ARRANGEMENTS

NOTE 15 – BORROWING ACTIVITIES AND ARRANGEMENTS

The following is a summary of our borrowings:

    

    

Annual

    

Interest Rate 

as of 

June 30, 

June 30, 

December 31, 

    

Maturity

    

2025

    

2025

    

2024

    

    

    

(in thousands)

Secured borrowings:

 

  

 

  

 

  

 

  

2026 mortgage loan(1)

 

2026

 

9.60

%  

$

251,624

$

231,148

Deferred financing costs – net

 

  

 

 

(2,874)

 

(3,753)

Premium – net(2)

 

  

 

  

 

12,192

 

15,915

Total secured borrowings

260,942

243,310

Unsecured borrowings:

 

  

 

  

 

  

 

  

Revolving Credit Facility(3)(4)

 

2025

 

5.64

%  

 

 

Senior notes and other unsecured borrowings:

2025 notes(3)(5)

 

2025

 

4.50

%  

 

 

400,000

2026 notes(3)

 

2026

 

5.25

%  

 

600,000

 

600,000

2027 notes(3)

 

2027

 

4.50

%  

 

700,000

 

700,000

2028 notes(3)

 

2028

 

4.75

%  

 

550,000

 

550,000

2029 notes(3)

 

2029

 

3.63

%

 

500,000

 

500,000

2030 notes(3)

2030

5.20

%

600,000

2031 notes(3)

2031

3.38

%

700,000

700,000

2033 notes(3)

2033

3.25

%

700,000

700,000

2025 Term Loan(3)(6)

2025

 

5.60

%

 

428,500

 

428,500

OP Term Loan(7)

 

2025

 

N/A

 

 

50,000

Deferred financing costs – net

 

  

 

 

(17,930)

 

(14,843)

Discount – net

 

  

 

  

 

(21,079)

 

(18,108)

Total senior notes and other unsecured borrowings – net

 

  

 

  

 

4,739,491

 

4,595,549

Total unsecured borrowings – net

 

  

 

  

 

4,739,491

 

4,595,549

Total secured and unsecured borrowings – net(8)(9)

 

  

 

  

$

5,000,433

$

4,838,859

(1)Wholly owned subsidiaries of Omega OP are the obligors on this borrowing. Loan is denominated in British Pounds Sterling (“GBP”).
(2)Represents the remaining fair value adjustment associated with the 2026 mortgage loan, that was assumed as part of an asset acquisition in July 2024, that is being amortized over the remaining contractual term of the loan.
(3)Guaranteed by Omega OP.
(4)As of June 30, 2025 and December 31, 2024, there were no borrowings outstanding under Omega’s $1.45 billion senior unsecured multicurrency revolving credit facility (“Revolving Credit Facility”). The applicable interest rate on the USD tranche and on the GBP borrowings under the alternative currency tranche of the Revolving Credit Facility were 5.64% and 5.54%, respectively, as of June 30, 2025. In April 2025, the maturity date was extended from April 30, 2025 to October 30, 2025 following Omega’s election to utilize one of two six-month extension options.
(5)The Company repaid $400 million of 4.50% senior notes that matured on January 15, 2025 using available cash.
(6)The weighted average interest rate of the $428.5 million term loan (the “2025 Term Loan”) has been adjusted to reflect the impact of the interest rate swaps that effectively fix the SOFR-based portion of the interest rate at 4.047%. In July 2025, the maturity date of the 2025 Term Loan was extended from August 8, 2025 to August 8, 2026 following Omega’s election to utilize one of two 12-month extension options.
(7)On April 29, 2025, Omega repaid the $50 million term loan (“OP Term Loan”) using available cash prior to its original maturity date. Omega OP was the obligor on this borrowing.
(8)All borrowings are direct borrowings of Parent unless otherwise noted.
(9)Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of June 30, 2025 and December 31, 2024, we were in compliance with all applicable covenants for our borrowings.

$600 Million Senior Note Issuance

On June 20, 2025, Omega issued $600 million of Senior Notes due 2030 (the “2030 Senior Notes”) that mature on July 1, 2030 and bear interest at a fixed rate of 5.200% per annum, payable semi-annually on January 1 and July 1 of each year, commencing on January 1, 2026. The 2030 Senior Notes were sold at an issue price of 99.118% of their face value, resulting in a discount of $5.3 million. We incurred $5.6 million of deferred costs in connection with the issuance. The net proceeds from the issuance will be used for general corporate purposes, which may include, among other things, repayment of our existing indebtedness and future acquisition or investment opportunities in healthcare-related real estate properties and to pay certain fees and expenses related to the offering.